David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
First Bancorp
FBP
$4.31B
| $13.6M | 0.01% |
1,207,818
-528,167
| -30% | -$5.55M |
|
1077
Rocket Pharmaceuticals
RCKT
$388M
| $13.6M | 0.01% |
306,250
-12,388
| -4% | -$680K |
|
1078
CRH
CRH
$63.7B
| $13.6M | 0.01% |
+288,741
| New | +$13M |
|
1079
PUT
Newmont
NEM
$139B
| $13.6M | 0.01% |
225,000
+103,200
| +85% | +$6.17M |
|
|
SRNGU
1080
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
| $13.5M | 0.01% |
+1,338,872
| New | +$13.9M |
|
1081
CALL
Nike
NKE
$60.5B
| $13.5M | 0.01% |
101,900
-204,900
| -67% | -$28.5M |
|
|
STMP
1082
PUT
DELISTED
Stamps.com, Inc.
STMP
| $13.5M | 0.01% |
67,500
+10,000
| +17% | +$2.13M |
|
|
Y
1083
CALL
DELISTED
Alleghany Corp
Y
| $13.5M | 0.01% |
21,500
+1,500
| +8% | +$928K |
|
1084
PUT
Workday
WDAY
$49.2B
| $13.4M | 0.01% |
54,100
-65,100
| -55% | -$16.1M |
|
1085
Silicon Motion
SIMO
$8.25B
| $13.4M | 0.01% |
226,088
-26,730
| -11% | -$1.52M |
|
1086
W.W. Grainger
GWW
$62.3B
| $13.4M | 0.01% |
33,423
-57,044
| -63% | -$22.1M |
|
|
ADN
1087
DELISTED
Advent Technologies
ADN
| $13.4M | 0.01% |
+33,333
| New | +$15.1M |
|
1088
Gaotu Techedu
GOTU
$403M
| $13.4M | 0.01% |
395,179
+384,615
| +3,641% | +$31.3M |
|
1089
Pediatrix Medical
MD
$2.16B
| $13.4M | 0.01% |
525,283
-380,400
| -42% | -$9.74M |
|
1090
Tenaris
TS
$27B
| $13.3M | 0.01% |
586,036
-329,506
| -36% | -$6.3M |
|
|
GTS
1091
DELISTED
Triple-S Management Corporation
GTS
| $13.2M | 0.01% |
508,169
-18,518
| -4% | -$457K |
|
1092
PUT
Markel Group
MKL
$22.5B
| $13.2M | 0.01% |
11,600
-10,000
| -46% | -$10.8M |
|
|
BSN
1093
DELISTED
Broadstone Acquisition Corp.
BSN
| $13.2M | 0.01% |
+1,350,000
| New | +$13.6M |
|
1094
Gaming and Leisure Properties
GLPI
$12.8B
| $13.2M | 0.01% |
310,715
| – | – |
|
1095
CALL
Blackrock
BLK
$182B
| $13.1M | 0.01% |
17,400
-27,000
| -61% | -$19.6M |
|
1096
CALL
Equinix
EQIX
$104B
| $13.1M | 0.01% |
+19,300
| New | +$13.2M |
|
|
TVTY
1097
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $13M | 0.01% |
584,612
+237,650
| +68% | +$5.45M |
|
1098
PUT
Lemonade
LMND
$4.17B
| $13M | 0.01% |
+140,000
| New | +$18.1M |
|
1099
Celanese
CE
$4.97B
| $12.9M | 0.01% |
86,261
+60,236
| +231% | +$8.27M |
|
1100
Haemonetics
HAE
$4.93B
| $12.9M | 0.01% |
116,386
+79,166
| +213% | +$9.8M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.